Metallo-Î’-Lactamase Producing Clinical Isolates Of Acinetobacter Baumannii And Pseudomonas Aeruginosa In A Teaching Hospital Of Rural Gujarat-India.
Metallo-Î’-Lactamase Producing Clinical Isolates Of Acinetobacter Baumannii And Pseudomonas Aeruginosa
DOI:
https://doi.org/10.70284/njirm.v7i6.1388Keywords:
Multi drug resistance, Acinetobacter baumannii, Pseudomonas aeruginosa, Metallo-β-lactamaseAbstract
Background: Production of metallo-β-lactamase, an enzyme that hydrolyze a variety of β-lactams including carbapenems leaving little therapeutic option is increasing. To manage patients effectively, it is important to know the local prevalence of MBLs in the hospital. Present study was undertaken to determine prevalence of metallo-β-lactamase production along with the clinical profile of Acinetobacter baumannii and Pseudomonas aeruginosa. Methods: Prospective cross sectional study was carried out during December-2010 to November-2011. Relevant demographic and clinical details were collected. Acinetobacter baumannii and Pseudomonas aeruginosa were subjected to antimicrobial susceptibility testing by Kirby-bauer disc diffusion method and mini API system, (bioMerieux-France). Imipenem/meropenem resistant isolates were tested for metallo-β-lactamase production by imipenem-EDTA combined disc test. Results: 81 strains of Acinetobacter baumannii and 28 strains of Pseudomonas aeruginosa were isolated. Most common specimens from which Acinetobacter baumanni and Pseudomonas aeruginosa isolated were from respiratory tract i.e. 47(58%) and 12(42.9%) respectively. Majority of the strains of Acinetobacter baumannii 44 (54.3%) and Pseudomonas aeruginosa 17 (60.7%) were isolated from non critical areas. Both organisms showed high prevalence of multidrug resistance with MBLs production of 29.6% in Acinetobacter baumannii and 42.9% in Pseudomonas aeruginosa. Conclusion: Metallo-β-lactamase-mediated carbapenem resistance is a significant threat in hospitalized patients. It should be addressed with rapid detection and stringent infection control measures. [Yagnesh P NJIRM 2016; 7(6): 29-33]
References
2. A Varaiya, M Kulkarni, P Bhalekar, J Dogra, Incidence of Carbapenem-resistance Pseudomonas aeruginosa in Diabetes and Cancer patients, Indian Journal of Medical Microbiology. 2008; 26(3): 238-240.
3. S Irfan, A zafar, D Guhar, TAhsan, R Hasan Metallo-β-lactamase producing clinical isolates of Acinetobacter species and Pseudomonas aeruginosa from intensive care unit patients of a tertiary care hospital, Indian Journal of Medical Microbiology. (2008); 26(3): 243-45.
4. Clare Franklin, Lisa Liolios, Anton Y Peleg, Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing Gram negative bacilli in the clinical laboratory, Journal of Clinical Microbiology. (2006); 44(9):3139-3144.
5. M Purohit, DK Mendiratta, VS Deotale, M Madhan, A manoharan, P Narang, Detection of metallo-β-lactamase producing Acinetobacter baumannii using microbiological assay, disc synergy test and PCR, Indian Journal of Medical Microbiology. 2012; 30(4): 456-61.
6. S Buchunde, DK Mendiratta, V Deotale, P Narang, Comparison of disc and MIC reduction methods with polymerase chain reaction for the detection of metallo-β-lactamase in Pseudomonas aeruginosa, Indian Journal of Medical Microbiology. 2012; 30(2): 170-174.
7. Clinical and Laboratory standards institute (CLSI), performance standards for antimicrobial susceptibility testing, 18th informational supplements CLSI Document M 100 January-2011.
8. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin Microbiol. 2002; 40(10):3798-3801.
10. Timothy R. Walsh, Mark A Toleman, Laurent Poirel and Patrice Nordmann, Metallo-β-lactamases: the Quiet before the Storm?, Clinical Microbiology reviews. 2005; 18(2):306-325.
11. M. Noori, A. Karimi, F. Fallah et al., High prevalence of Metallo-β-lactamase producing Acinetobacter baumannii isolated from two hospital of Tehran, Iran. Archives of Pediatric Infectious diseases. 2014; 2(3): Article ID e15439.
12. R.M.L. de Carvalho, S.G. Marques, L.H.B. Goncalves, A.G. Abreu,S.G. Monteiro, and A.G. Goncalves Phenotypic detection of metallo-β-lactamase in Pseudomonas aeruginosa and Acinetobacter baumannii isolated from hospitalized patients in Sao Luis, State of Maranhao, Brazil. Revista da Sociedade Brasileira de Medicine Tropical. 2013; 46(4):506-509.
13. Noyal MJ, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative gram-negative bacteria. Indian J Med Res. 2009; 129(6):707-12.
14. A.V.Kumar, V.S. Pillai, K. Dinesh, and S. Karim, The phenotypic detection of carbapenemase in meropenem resistant Acinetobacter calcoaceticus-baumannii complex in a tertiary care hospital in South India. Journal of clinical and Diagnostic Research 2011; 5(2):223-226.
15. N. OzkalayYilmaz, N Agus, E Bozeal, A Uzel, Prevalence and molecular characterization of metallo-β-lactamase producing strains of imipenem resistance Pseudomonas aeruginosa in Turkey. Indian Journal of Medical Microbiology, 2014; 32(3):349-350.
16. Muneeza Anwar, Hassan Ejaz, Aizza Zafar, and Hamdan Hamid, Phenotypic Detection of Metallo-Beta-Lactamase in Carbapenem Resistant Acinetobacter baumannii Isolated from Pediatric Patients in Pakistan. Journal of Pathogens. Volume 2016; Article ID 8603964.
17. P. N. Pandya, B.S. Prajapati, J.S. Mehta, M.K. Kikani, and J.P. Joshi, Evaluation of various methods for detection of MBL production in Gram negative bacilli. International Journal of Biological and Medical Research. 2011; 2(3):775-777.
18. Pitout JD, Gregson DB, Poirel L., McClure J A, Le P, Church DL., Detection of Pseudomonas aeruginosa producing metallo-β-lactamase in a large centralized laboratory. J .Clin Microbiol. 2005; 43(3):129-135.
19. S. Islahi, F. Ahmad, V. Khare et.al. Prevalence and resistance pattern Acinetobacter species in hospitalized patients in a tertiary care centre. Journal of Evoluation of Medical and Dental sciences. 2014; 3(17):4629-4635. 20. R. H. Sunenshine, M.O. Wright, L.L. Maragakis et.al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerging Infectious Disease. 2007; 13(1):97-103.9. B Behera, P Mathur, A Das, A Kapil, V Sharma, An Evaluation of four different phenotypic Techniques for detection of metallo-β-lactamase producing Pseudomonas aeruginosa, Indian Journal of Medical Microbiology. 2008; 26(3):233-237.
